alexa Gemcitabine and Hemolytic Uremic Syndrome: a Case Repor
ISSN: 2165-7831

Journal of Blood & Lymph
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Case Report

Gemcitabine and Hemolytic Uremic Syndrome: a Case Report

Villalba NL1*, Merzouki T1, González NS2, Ortiz MBA2, Kechida M3, Bailon MM4, Zamorano NF1, Saint-Mezard V1 and Teguo MT1

1Centre Hospitalier Saint Cyr, France

2Hospital Universitario de Gran Canaria Dr Negrin, Spain

3Hôpital Universitaire Fattouma Bourguiba, Tunisia

4Hospital Universitario San Carlos, Spain

*Corresponding Author:
Villalba NL
Centre Hospitalier Saint Cyr. Route de Fumel
Lieu-dit Brignol Romas, 47300
Villeneuve-sur-Lot, France
Tel: 33629383092
E-mail: [email protected]

Received Date: April 29, 2017; Accepted Date: May 16, 2017; Published Date: May 23, 2017

Citation: Villalba NL, Merzouki T, González NS, Ortiz MBA, Kechida M, et al. (2017) Gemcitabine and Hemolytic Uremic Syndrome: a Case Report. J Blood Lymph 7: 168. doi: 10.4172/2165-7831.1000168

Copyright: © 2017 Villalba NL, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.



We are reporting the case of a 61 year old male patient with a medical history of pancreatic cancer on chemotherapy presenting a uremic hemolytic syndrome after the administration of gemcitabine. The renal function progressively worsened during his stay in spite of general measures and steroids, leading to the death at day 12 of admission.


Share This Page

Additional Info

Loading Please wait..
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version